Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Non-Current Deffered Revenue (2022 - 2023)

Historic Non-Current Deffered Revenue for TriSalus Life Sciences (TLSIW) over the last 2 years, with Q2 2023 value amounting to $8.8 million.

  • TriSalus Life Sciences' Non-Current Deffered Revenue changed 0.0% to $8.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $8.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $8.8 million for FY2022, which is N/A changed from last year.
  • TriSalus Life Sciences' Non-Current Deffered Revenue amounted to $8.8 million in Q2 2023, which was down 0.0% from $8.8 million recorded in Q1 2023.
  • Over the past 5 years, TriSalus Life Sciences' Non-Current Deffered Revenue peaked at $8.8 million during Q1 2022, and registered a low of $8.8 million during Q1 2022.